Natural product-derived PD-1 pathway blockade for Human cancer therapy: Berberine, isolated from Phellodendron amurense and Berberis among others, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene, 18/January/2017, 10.02 pm

Vitamin-E-based therapy for glucose homeostasis and TIIDM: α-Tocopherol, a form of Vitamin-E found in Almonds, Sunflower seeds, and Tomato among others, increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 18/January/2017, 7.00 am
January 18, 2017
Anti-telomerase cancer therapy: MiR-9600 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of it target gene, 18/January/2017, 10.47 pm
January 18, 2017
Show all

Introduction:What they say

A recent study from Cell Signalling Section, Division of Immunology, Department of Pathology, Tennis Court Road, University of Cambridge, Cambridge CB2 1QP, UK shows that “Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.” This study was published in the 16 February 2016 issue of Immunity (one of the best journals in Immunology with an impact factor of 20+) by Prof Rudd CE, Taylor A and others.


What we say

price-50[easy_payment currency=”USD”]

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived PD-1 pathway blockade for Human cancer therapy:  Berberine, isolated from Phellodendron amurense and Berberis among others, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene


What is known?

It has recently been shown that blocking PD-1 with antibodies one could make tumors shrink. This work, relating to Cancer immunotherapy, has been chosen as Science’s breakthrough of the year.


Research Findings

This study suggests a natural product-based Human cancer therapy.  Berberine, by increasing the expression of its target gene, it may suppress the expression of Glycogen synthase kinase 3-β (figures 1-3).

Figure 1. Berberine, found in Phellodendron amurense  and Berberis, as indicated below, augments anti-tumor immunity via down regulation of PD-1

Berberine

Figure 2. Berberine is also found in Berberis

berberine1

Fig 3. Berberine boosts anti-tumor immunity. Berberine, isolated from Phellodendron amurense and Berberis, increases T-bet expression, inhibits PD-1 expression, and augments anti-tumor immunity

Thereby, it may: (a) increase transcription factor T-bet expression; (b) inhibit co-inhibitory receptor PD-1 expression;  (c) increase CD8(+) cytotoxic T lymphocyte function; (d) augment anti-tumor activity; & (e) inhibit metastatic cancer progression (fig 3).


Therapeutic opportunity

Thus, pharmacological formulations encompassing Berberine or its analogues may be used to inhibit the progression of tumors.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $50

Undisclosed information: How does   Berberine  suppress the expression of PD-1 to promote anti-tumor immunity?

# Research cooperation

For purchase and payment information, you may reach us at admin@genomediscovery.org


References:

Citation: Boominathan, L., Natural product-derived PD-1 pathway blockade for Human cancer therapy:  Berberine, isolated from Phellodendron amurense and Berberis among others, decreases the activity of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene, 18/January/2017, 10.02 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.